Joke de Meris

3.1k total citations
19 papers, 319 citations indexed

About

Joke de Meris is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joke de Meris has authored 19 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joke de Meris's work include Platelet Disorders and Treatments (19 papers), Blood groups and transfusion (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (8 papers). Joke de Meris is often cited by papers focused on Platelet Disorders and Treatments (19 papers), Blood groups and transfusion (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (8 papers). Joke de Meris collaborates with scholars based in Netherlands. Joke de Meris's co-authors include Frank W.G. Leebeek, Karin Fijnvandraat, Johanna G. van der Bom, Marjon H. Cnossen, Karina Meijer, Jeroen Eikenboom, Britta A. P. Laros‐van Gorkom, Eveline P. Mauser‐Bunschoten, Yvonne Sanders and Karin P. M. van Galen and has published in prestigious journals such as Blood, British Journal of Haematology and Journal of Thrombosis and Haemostasis.

In The Last Decade

Joke de Meris

18 papers receiving 309 citations

Peers

Countries citing papers authored by Joke de Meris

Since Specialization

Citations

This map shows the geographic impact of Joke de Meris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joke de Meris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joke de Meris more than expected).

Fields of papers citing papers by Joke de Meris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joke de Meris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joke de Meris. The network helps show where Joke de Meris may publish in the future.

Co-authorship network of co-authors of Joke de Meris

This figure shows the co-authorship network connecting the top 25 collaborators of Joke de Meris. A scholar is included among the top collaborators of Joke de Meris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joke de Meris. Joke de Meris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Sexuality and bleeding in von Willebrand disease 2025 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Hester Pastoor, Jeroen Eikenboom, Karin Fijnvandraat, Paula F. Ypma, Floor Heubel-Moenen, Karin P. M. van Galen, Evelien P. Mauser‐Bunschoten, Karina Meijer, Saskia E.M. Schols, Marjon H. Cnossen, (unknown), Joke de Meris, Ferdows Atiq, Marieke J.H.A. Kruip, Frank W.G. Leebeek, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study 2024 ·Journal of Thrombosis and Haemostasis ·(unknown), Ferdows Atiq, (unknown), Karin Fijnvandraat, Karin P. M. van Galen, Marjon H. Cnossen, Saskia E.M. Schols, Marieke J. H. A. Kruip, Waander L. van Heerde, Joke de Meris, Johanna G. van der Bom, Jeroen Eikenboom, Karina Meijer, Frank W.G. Leebeek, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
3	Patient‐reported data on the severity of Von Willebrand disease 2024 ·Haemophilia ·(unknown), Karin Fijnvandraat, Marieke J. H. A. Kruip, Joke de Meris, Saskia E.M. Schols, Karina Meijer, Johanna G. van der Bom, Marjon H. Cnossen, Karin P. M. van Galen, Ferdows Atiq, Jeroen Eikenboom, Frank W.G. Leebeek, (unknown)	1
4	Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), Joke de Meris, Manon C.W. Spaander, Saskia E.M. Schols, Paula F. Ypma, Floor Heubel-Moenen, Lize F. D. van Vulpen, Michiel Coppens, Johanna G. van der Bom, Karin Fijnvandraat, Karina Meijer, Jeroen Eikenboom, Samantha C. Gouw, Frank W.G. Leebeek, Marieke J.H.A. Kruip	2
5	Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease 2022 ·Blood Advances ·Ferdows Atiq, (unknown), (unknown), Johan Boender, (unknown), Waander L. van Heerde, (unknown), (unknown), (unknown), Joke de Meris, Saskia E.M. Schols, (unknown), Johanna G. van der Bom, Marjon H. Cnossen, Karina Meijer, Karin Fijnvandraat, Jeroen Eikenboom, Frank W.G. Leebeek	9
6	Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients 2022 ·British Journal of Haematology ·(unknown), Ferdows Atiq, Petra E. Bürgisser, (unknown), Karina Meijer, Jeroen Eikenboom, Karin Fijnvandraat, Karin P. M. van Galen, Joke de Meris, Saskia E.M. Schols, Johanna G. van der Bom, Marjon H. Cnossen, Jan Voorberg, Frank W.G. Leebeek, Ruben Bierings, A.J. Gerard Jansen, (unknown)	3
7	Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype 2022 ·HemaSphere ·Ferdows Atiq, Johan Boender, Waander L. van Heerde, (unknown), (unknown), (unknown), Marjon H. Cnossen, Britta A. P. Laros‐van Gorkom, Joke de Meris, Karin Fijnvandraat, Johanna G. van der Bom, Karina Meijer, Karin P. M. van Galen, Jeroen Eikenboom, Frank W.G. Leebeek, (unknown)	17
8	Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders 2021 ·EClinicalMedicine ·Ferdows Atiq, (unknown), Marieke C. Punt, Karin P. M. van Galen, Roger E. G. Schutgens, Karina Meijer, Marjon H. Cnossen, Britta A. P. Laros‐van Gorkom, Marjolein Peters, Laurens Nieuwenhuizen, Marieke J.H.A. Kruip, Joke de Meris, Johanna G. van der Bom, F.J.M. van der Meer, Karin Fijnvandraat, (unknown), Waander L. van Heerde, Jeroen Eikenboom, Frank W.G. Leebeek, Saskia E.M. Schols	42
9	Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease 2021 ·HemaSphere ·Johan Boender, Ferdows Atiq, Marjon H. Cnossen, Johanna G. van der Bom, Karin Fijnvandraat, Joke de Meris, Moniek P.M. de Maat, Karin P. M. van Galen, Britta A. P. Laros‐van Gorkom, Karina Meijer, Jeroen Eikenboom, Frank W.G. Leebeek	10
10	Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype 2021 ·Haemophilia ·(unknown), (unknown), Joke de Meris, Saskia E.M. Schols, Karin P. M. van Galen, Karina Meijer, Marjon H. Cnossen, Johanna G. van der Bom, Karin Fijnvandraat, Jeroen Eikenboom, Ferdows Atiq, Frank W.G. Leebeek, (unknown)	3
11	Clinically relevant differences between assays for von Willebrand factor activity 2018 ·Journal of Thrombosis and Haemostasis ·Johan Boender, Jeroen Eikenboom, Johanna G. van der Bom, Karina Meijer, Joke de Meris, Karin Fijnvandraat, Marjon H. Cnossen, Britta A. P. Laros‐van Gorkom, Waander L. van Heerde, Evelien P. Mauser‐Bunschoten, Moniek P.M. de Maat, Frank W.G. Leebeek	37
12	Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease 2018 ·British Journal of Haematology ·Ferdows Atiq, Karina Meijer, Jeroen Eikenboom, Karin Fijnvandraat, Eveline P. Mauser‐Bunschoten, Karin P. M. van Galen, Marten R. Nijziel, Paula F. Ypma, Joke de Meris, Britta A. P. Laros‐van Gorkom, Johanna G. van der Bom, Moniek PM de Maat, Marjon H. Cnossen, Frank W.G. Leebeek, (unknown)	34
13	Sports participation and physical activity in patients with von Willebrand disease 2018 ·Haemophilia ·Ferdows Atiq, Eveline P. Mauser‐Bunschoten, Jeroen Eikenboom, Karin P. M. van Galen, Karina Meijer, Joke de Meris, Marjon H. Cnossen, (unknown), Britta A. P. Laros‐van Gorkom, Laurens Nieuwenhuizen, Johanna G. van der Bom, Karin Fijnvandraat, Frank W.G. Leebeek, (unknown)	17
14	Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease 2018 ·Haemophilia ·(unknown), Yvonne Sanders, Joke de Meris, Frank W.G. Leebeek, Karina Meijer	9
15	Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study 2017 ·Haematologica ·Karin P. M. van Galen, P. de Kleijn, Wouter Foppen, Jeroen Eikenboom, Karina Meijer, Roger E. G. Schutgens, Kathelijn Fischer, Marjon H. Cnossen, Joke de Meris, Karin Fijnvandraat, Johanna G. van der Bom, Britta A. P. Laros‐van Gorkom, Frank W.G. Leebeek, Eveline P. Mauser‐Bunschoten	24
16	Plasma levels of plasminogen activator inhibitor‐1 and bleeding phenotype in patients with von Willebrand disease 2017 ·Haemophilia ·(unknown), Johan Boender, (unknown), Jeroen Eikenboom, (unknown), Eveline P. Mauser‐Bunschoten, Karina Meijer, Joke de Meris, Britta A. P. Laros‐van Gorkom, Johanna G. van der Bom, Frank W.G. Leebeek, D.C. Rijken, Shirley Uitte de Willige, (unknown)	4
17	No Association Between Normalization of VWF Levels and Bleeding Phenotype in Patients with Type 1 VWD - from the Win Study 2016 ·Blood ·Johan Boender, Jeroen Eikenboom, Karin Fijnvandraat, Waander L. van Heerde, Karina Meijer, Evelien P. Mauser‐Bunschoten, Marjon H. Cnossen, Joke de Meris, (unknown), (unknown), Frank W.G. Leebeek	2
18	von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease 2015 ·Blood ·Yvonne Sanders, Dafna J. Groeneveld, Karina Meijer, Karin Fijnvandraat, Marjon H. Cnossen, Johanna G. van der Bom, Michiel Coppens, Joke de Meris, Britta A. P. Laros‐van Gorkom, Eveline P. Mauser‐Bunschoten, Frank W.G. Leebeek, Jeroen Eikenboom, (unknown)	59
19	Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric‐specific bleeding 2015 ·American Journal of Hematology ·Yvonne Sanders, Karin Fijnvandraat, Johan Boender, Evelien P. Mauser‐Bunschoten, Johanna G. van der Bom, Joke de Meris, Frans J. Smiers, Bernd Granzen, Paul Brons, R. Y. J. Tamminga, Marjon H. Cnossen, Frank W.G. Leebeek, (unknown)	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact